UiPath PATH 深 沪
等待开盘 09-30 09:30:00 美东时间
12.32
+0.130
+1.07%
华盛通- 最 高12.35
- 今 开12.25
- 成交量 3617.72万股
- 最 低 11.99
- 昨 收 12.19
- 总市值 64.21亿
- 52周最高 19.84
- 市盈率 静 23.77
- 换手率 0.01%
- 52周最低 9.2002
- 委 比 69.70%
- 总股本 5.21亿
- 历史最高 90.00
- 量 比 0.75
- 振 幅 2.95%
- 历史最低 9.2002
- 每 手 1
- 风险率 2.49%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 潜在涨幅919.61%！HC Wainwright上调NeuroSense Therapeutics目标价至52美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持NeuroSense Therapeutics"买入"评级，目标价从8美元升至52美元；HC Wainwright & Co.：维持艾切托"买入"评级，目标价从27美元升至34美元
09-29 08:33
This PepsiCo Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Monday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. Deutsche Bank analyst Steve Powers downgraded PepsiCo Inc (NASDAQ:PEP) from Buy to Hold and cut t...
09-29 01:47
Why Is UiPath Stock Falling on Monday?
UiPath Inc. (NYSE:PATH) stock fell on Monday after DA Davidson downgraded the company to Underperform and set a $10 price target. The downgrade follows several price forecast cuts from Wall Street brokerages since the company’s Investor Day on Sept. 22. The Nasdaq is down 1.18% while the S&P 500 has...
09-28 23:58
美股大行评级 | Meta获4家机构看好！目标价最高升至950美元；好市多绩后齐遭机构降低目标价
今日重点评级关注：古根海姆：维持Damora Therapeutics"买入"评级，目标价从40美元升至60美元；HC Wainwright & Co.：维持Rezolute"买入"评级，目标价从5美元升至10美元
09-28 12:37
美股大行评级 | Meta获4家机构齐升目标价，最高看至995美元！麦当劳遭6家机构下调，最低看至260美元
今日重点评级关注：Canaccord Genuity：维持Aurora Innovation"买入"评级，目标价从15美元升至17美元；摩根大通：维持皇家加勒比邮轮"超配"评级，目标价从345美元升至394美元
09-25 15:55
美股大行评级 | 汽车地带绩后遭10家机构降目标价！最低看至3000美元；美光、微软、Meta齐获看多
今日重点评级关注：Leerink Partners：维持塞德斯医疗"跑赢大市"评级，目标价从70美元升至88美元；HC Wainwright & Co.：维持TriSalus Life Sciences"买入"评级，目标价从11美元升至12美元
09-24 16:10
UiPath Stock Falls as Analyst Highlights Expanding AI Opportunity
UiPath Inc (NYSE:PATH) came under pressure on Wednesday, following the start of the company’s three-day flagship conference, Fusion 2026. The Analyst Day on Tuesday highlighted the company’s expanding AI opportunity, according to Needham. • UiPath stock is holding steady today. What’s ahead for PATH...
09-24 00:46
UiPath Stock Falls as Analyst Highlights Expanding AI Opportunity
UiPath Inc (NYSE:PATH) came under pressure on Wednesday, following the start of...
09-24 00:46
UiPath announces new AI upgrades: Will PATH stock rebound now?
UiPath (PATH) shares are down nearly 5% over the past week, but the company’s platform upgrades announced on Wednesday could give the stock a fresh catalyst. The company rolled out new and expanded ca...
09-23 21:11
Needham Reiterates Buy on UiPath, Maintains $22 Price Target
Needham analyst Scott Berg reiterates UiPath (NYSE:PATH) with a Buy and maintains $22 price target.
09-23 19:11
